Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy
Rationale Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobuli...
Saved in:
Published in | Journal of internal medicine Vol. 276; no. 3; pp. 269 - 284 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley
01.09.2014
BlackWell Publishing Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 0954-6820 1365-2796 1365-2796 |
DOI | 10.1111/joim.12195 |
Cover
Abstract | Rationale
Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying NXG remains unknown although the involvement of MIg is suspected.
Objective
To provide further insights into the pathophysiology of NXG, we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [NXG (n = 8) and NX (n = 8)] associated with monoclonal IgG relative to the relevant controls.
Results
The lipid profile of patients with NXG was characterized by a low HDL‐C phenotype and an abnormal distribution of HDL particles. Sera from patients with NXG induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the HDL capacity to promote cholesterol efflux from macrophages, which was not found in the case of NX. The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro‐inflammatory cytokines (TNFα and IL‐6), soluble cytokine receptors (sIL‐6R, sTNFRI and sTNFRII), adhesion molecules (VCAM‐1 and ICAM‐1) and chemokines (MCP‐1, IL‐8 and MIP‐1α) were observed in both patients with NXG and NX, revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti‐inflammatory HDL. However, patients with NXG were distinguished by elevated levels of IL‐15 and a marked increase in the rate of intermediate CD14++CD16+ monocytes.
Conclusion
This study revealed that NXG is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins. |
---|---|
AbstractList | Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying NXG remains unknown although the involvement of MIg is suspected.
To provide further insights into the pathophysiology of NXG, we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [NXG (n = 8) and NX (n = 8)] associated with monoclonal IgG relative to the relevant controls.
The lipid profile of patients with NXG was characterized by a low HDL-C phenotype and an abnormal distribution of HDL particles. Sera from patients with NXG induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the HDL capacity to promote cholesterol efflux from macrophages, which was not found in the case of NX. The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro-inflammatory cytokines (TNFα and IL-6), soluble cytokine receptors (sIL-6R, sTNFRI and sTNFRII), adhesion molecules (VCAM-1 and ICAM-1) and chemokines (MCP-1, IL-8 and MIP-1α) were observed in both patients with NXG and NX, revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti-inflammatory HDL. However, patients with NXG were distinguished by elevated levels of IL-15 and a marked increase in the rate of intermediate CD14++CD16+ monocytes.
This study revealed that NXG is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins. Rationale Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying NXG remains unknown although the involvement of MIg is suspected. Objective To provide further insights into the pathophysiology of NXG, we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [NXG (n = 8) and NX (n = 8)] associated with monoclonal IgG relative to the relevant controls. Results The lipid profile of patients with NXG was characterized by a low HDL‐C phenotype and an abnormal distribution of HDL particles. Sera from patients with NXG induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the HDL capacity to promote cholesterol efflux from macrophages, which was not found in the case of NX. The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro‐inflammatory cytokines (TNFα and IL‐6), soluble cytokine receptors (sIL‐6R, sTNFRI and sTNFRII), adhesion molecules (VCAM‐1 and ICAM‐1) and chemokines (MCP‐1, IL‐8 and MIP‐1α) were observed in both patients with NXG and NX, revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti‐inflammatory HDL. However, patients with NXG were distinguished by elevated levels of IL‐15 and a marked increase in the rate of intermediate CD14++CD16+ monocytes. Conclusion This study revealed that NXG is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins. Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying NXG remains unknown although the involvement of MIg is suspected.RATIONALEXanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying NXG remains unknown although the involvement of MIg is suspected.To provide further insights into the pathophysiology of NXG, we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [NXG (n = 8) and NX (n = 8)] associated with monoclonal IgG relative to the relevant controls.OBJECTIVETo provide further insights into the pathophysiology of NXG, we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [NXG (n = 8) and NX (n = 8)] associated with monoclonal IgG relative to the relevant controls.The lipid profile of patients with NXG was characterized by a low HDL-C phenotype and an abnormal distribution of HDL particles. Sera from patients with NXG induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the HDL capacity to promote cholesterol efflux from macrophages, which was not found in the case of NX. The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro-inflammatory cytokines (TNFα and IL-6), soluble cytokine receptors (sIL-6R, sTNFRI and sTNFRII), adhesion molecules (VCAM-1 and ICAM-1) and chemokines (MCP-1, IL-8 and MIP-1α) were observed in both patients with NXG and NX, revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti-inflammatory HDL. However, patients with NXG were distinguished by elevated levels of IL-15 and a marked increase in the rate of intermediate CD14++CD16+ monocytes.RESULTSThe lipid profile of patients with NXG was characterized by a low HDL-C phenotype and an abnormal distribution of HDL particles. Sera from patients with NXG induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the HDL capacity to promote cholesterol efflux from macrophages, which was not found in the case of NX. The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro-inflammatory cytokines (TNFα and IL-6), soluble cytokine receptors (sIL-6R, sTNFRI and sTNFRII), adhesion molecules (VCAM-1 and ICAM-1) and chemokines (MCP-1, IL-8 and MIP-1α) were observed in both patients with NXG and NX, revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti-inflammatory HDL. However, patients with NXG were distinguished by elevated levels of IL-15 and a marked increase in the rate of intermediate CD14++CD16+ monocytes.This study revealed that NXG is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins.CONCLUSIONThis study revealed that NXG is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins. |
Author | Saint‐Charles, F. Robillard, P. Chapman, M. John Giral, P. Guerin, M. Frisdal, E. Cathébras, P. Goff, W. Le Szalat, R. Fermand, J.‐P. Bruckert, E. Olivier, M. Lesnik, P. Pirault, J. Villard, E. F. Carrié, A. |
Author_xml | – sequence: 1 givenname: R. surname: Szalat fullname: Szalat, R. organization: Institut Universitaire d'Hématologie – sequence: 2 givenname: J. surname: Pirault fullname: Pirault, J. organization: Institute of Cardiometabolism and Nutrition (ICAN) – sequence: 3 givenname: J.‐P. surname: Fermand fullname: Fermand, J.‐P. organization: Institut Universitaire d'Hématologie – sequence: 4 givenname: A. surname: Carrié fullname: Carrié, A. organization: Hôpital Pitié‐Salpêtrière – sequence: 5 givenname: F. surname: Saint‐Charles fullname: Saint‐Charles, F. organization: Institute of Cardiometabolism and Nutrition (ICAN) – sequence: 6 givenname: M. surname: Olivier fullname: Olivier, M. organization: Institute of Cardiometabolism and Nutrition (ICAN) – sequence: 7 givenname: P. surname: Robillard fullname: Robillard, P. organization: Institute of Cardiometabolism and Nutrition (ICAN) – sequence: 8 givenname: E. surname: Frisdal fullname: Frisdal, E. organization: Institute of Cardiometabolism and Nutrition (ICAN) – sequence: 9 givenname: E. F. surname: Villard fullname: Villard, E. F. organization: Institute of Cardiometabolism and Nutrition (ICAN) – sequence: 10 givenname: P. surname: Cathébras fullname: Cathébras, P. organization: Service de médecine interne hôpital Nord – sequence: 11 givenname: E. surname: Bruckert fullname: Bruckert, E. organization: Hôpital Pitié‐Salpêtrière – sequence: 12 givenname: M. John surname: Chapman fullname: Chapman, M. John organization: Institute of Cardiometabolism and Nutrition (ICAN) – sequence: 13 givenname: P. surname: Giral fullname: Giral, P. organization: Hôpital Pitié‐Salpêtrière – sequence: 14 givenname: M. surname: Guerin fullname: Guerin, M. organization: Institute of Cardiometabolism and Nutrition (ICAN) – sequence: 15 givenname: P. surname: Lesnik fullname: Lesnik, P. organization: Institute of Cardiometabolism and Nutrition (ICAN) – sequence: 16 givenname: W. Le surname: Goff fullname: Goff, W. Le organization: Institute of Cardiometabolism and Nutrition (ICAN) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24428816$$D View this record in MEDLINE/PubMed https://hal.science/hal-03624912$$DView record in HAL |
BookMark | eNp9kUFv1DAQhS3Uim4LF34AyhGQUmzHduwLUlUBXbSoHNqz5TjejSvHs8TZlvx7vE2LaIXwxbLne29Gb47RQYToEHpD8CnJ5-MN-P6UUKL4C7QgleAlrZU4QAusOCuFpPgIHad0gzGpsMAv0RFljEpJxAItf3RT8rA1YwcBNlMB6yI6O0DjYfS2-GVirmwGE3cBelPc-bEreohgA0QTio3p-3v19Aodrk1I7vXDfYKuv3y-Or8oV5dfl-dnq9JyynhpZMNFVde1bVshWYMtsdhZhmXjJHEVNzVXGaQtNUbh_CY1XtvGCCVbpkR1gj7Nvttd07vWujgOJujt4HszTBqM108r0Xd6A7ea5VQUk9ng_WzQPZNdnK30_g9XgjJF6C3J7LuHZgP83Lk06t4n60Iw0cEuacJ5RTBTqs7o27_n-uP8mHUG8AzkdFMa3FpbP5rRw35MHzTBer9OvV-nvl9nlnx4Jnl0_SdMZvjOBzf9h9TfLpffZ81vw9GxjA |
CitedBy_id | crossref_primary_10_1007_s00105_017_3995_3 crossref_primary_10_1016_j_mayocp_2021_05_012 crossref_primary_10_1177_2050313X211057929 crossref_primary_10_1007_s40620_021_01186_9 crossref_primary_10_1016_j_freeradbiomed_2015_08_010 crossref_primary_10_3324_haematol_2021_279118 crossref_primary_10_1111_dth_12744 crossref_primary_10_1161_ATVBAHA_118_310803 crossref_primary_10_1016_j_jdcr_2019_05_010 crossref_primary_10_1186_s13023_022_02291_z crossref_primary_10_1016_S1761_2896_16_78236_7 crossref_primary_10_1016_j_jdcr_2023_07_024 crossref_primary_10_1111_jdv_13786 crossref_primary_10_1001_jamadermatol_2019_4221 crossref_primary_10_1002_acr_22843 crossref_primary_10_1002_acr_23316 crossref_primary_10_1007_s00105_016_3839_6 crossref_primary_10_1016_j_clml_2016_04_009 crossref_primary_10_5021_ad_2020_32_1_53 crossref_primary_10_1111_jdv_14213 crossref_primary_10_5045_br_2022_2022035 crossref_primary_10_1001_jamadermatol_2024_2921 crossref_primary_10_17116_otorino20248902182 crossref_primary_10_1093_ehjcr_ytad469 crossref_primary_10_3390_ijms25053011 crossref_primary_10_1111_jdv_13577 crossref_primary_10_36290_vnl_2021_092 crossref_primary_10_1016_j_jdcr_2022_12_002 |
Cites_doi | 10.1056/NEJMoa054494 10.1016/j.cytogfr.2010.09.003 10.1016/j.ejcb.2010.11.005 10.1161/ATVBAHA.110.211342 10.1001/archinternmed.2009.551 10.1001/archderm.1986.01660230045008 10.1074/jbc.M111.264325 10.1097/MOL.0b013e328353ef07 10.1111/j.1365-4632.2009.03912.x 10.1016/j.tips.2011.09.004 10.1182/blood-2006-03-001164 10.1007/s00277-009-0849-9 10.1161/ATVBAHA.111.227181 10.1161/01.ATV.20.1.189 10.1136/jcp.56.1.64 10.1016/j.clim.2008.09.011 10.1194/jlr.M500255-JLR200 10.1161/01.RES.0000146094.59640.13 10.1189/jlb.0209082 10.1016/j.it.2011.05.005 10.1182/blood-2011-01-326827 10.4049/jimmunol.178.10.6581 10.1182/blood-2011-05-356907 10.1111/j.1346-8138.2006.00013.x 10.1016/j.jacc.2012.07.019 10.1093/eurheartj/ehq371 10.1586/erc.11.16 10.1016/S0021-9150(98)00260-3 10.1182/blood-2010-12-326355 10.1056/NEJMoa1001689 10.1172/JCI113960 10.1161/ATVBAHA.109.194548 10.1161/ATVBAHA.113.301468 |
ContentType | Journal Article |
Copyright | 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine. Distributed under a Creative Commons Attribution 4.0 International License 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine. 2014 |
Copyright_xml | – notice: 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine. – notice: Distributed under a Creative Commons Attribution 4.0 International License – notice: 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine. 2014 |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC 5PM |
DOI | 10.1111/joim.12195 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2796 |
EndPage | 284 |
ExternalDocumentID | PMC4279948 oai_HAL_hal_03624912v1 24428816 10_1111_joim_12195 JOIM12195 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Fondation de France – fundername: INSERM – fundername: Région Ile‐de‐France CODDIM |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29K 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AI. AIACR AIAGR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SJN SUPJJ TEORI TR2 UB1 V8K V9Y VH1 VVN W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZCG ZGI ZXP ZZTAW ~IA ~WT AAYXX CITATION AAHHS ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE CGR CUY CVF ECM EIF ESX IPNFZ NPM PKN WRC WUP 7X8 1XC 5PM |
ID | FETCH-LOGICAL-c5245-a8b563777cdd684b0c1c0ec408be81e35a7592452d2aa9035a170fcba698d4963 |
IEDL.DBID | DR2 |
ISSN | 0954-6820 1365-2796 |
IngestDate | Thu Aug 21 17:47:02 EDT 2025 Fri Sep 12 12:48:26 EDT 2025 Fri Jul 11 03:19:48 EDT 2025 Wed Feb 19 01:56:53 EST 2025 Thu Apr 24 23:10:59 EDT 2025 Wed Oct 01 01:20:25 EDT 2025 Sun Sep 21 06:21:41 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | HDL monocyte necrobiotic xanthogranuloma monoclonal immunoglobulin histiocytes immune complex |
Language | English |
License | Attribution http://creativecommons.org/licenses/by/3.0 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5245-a8b563777cdd684b0c1c0ec408be81e35a7592452d2aa9035a170fcba698d4963 |
Notes | Drs. Raphael Szalat and John Pirault contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 PMCID: PMC4279948 |
ORCID | 0000-0001-7570-3366 0000-0003-0150-1360 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.12195 |
PMID | 24428816 |
PQID | 1553104997 |
PQPubID | 23479 |
PageCount | 16 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4279948 hal_primary_oai_HAL_hal_03624912v1 proquest_miscellaneous_1553104997 pubmed_primary_24428816 crossref_citationtrail_10_1111_joim_12195 crossref_primary_10_1111_joim_12195 wiley_primary_10_1111_joim_12195_JOIM12195 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2014 |
PublicationDateYYYYMMDD | 2014-09-01 |
PublicationDate_xml | – month: 09 year: 2014 text: September 2014 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford, UK |
PublicationTitle | Journal of internal medicine |
PublicationTitleAlternate | J Intern Med |
PublicationYear | 2014 |
Publisher | Wiley BlackWell Publishing Ltd |
Publisher_xml | – name: Wiley – name: BlackWell Publishing Ltd |
References | 2012; 60 1989; 83 2011; 118 2006; 33 2000; 20 1999; 142 2011; 31 2011; 32 2009; 130 2012; 33 2006; 354 2009; 48 2009; 29 2003; 56 2011; 9 2010; 89 1980; 39 2010; 87 2007; 178 2006; 108 2004; 95 2013; 33 1986; 122 2011; 90 2006; 47 2011; 22 2010; 170 2012; 23 2010; 30 2011; 364 2011; 286 e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_35_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_15_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_20_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 Baudet MF (e_1_2_9_10_1) 1980; 39 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 21653326 - Blood. 2011 Aug 4;118(5):e16-31 20943670 - Eur Heart J. 2011 Jan;32(1):84-92 15486323 - Circ Res. 2004 Oct 15;95(8):764-72 20212186 - Arch Intern Med. 2010 Mar 8;170(5):478-84 22032984 - Trends Pharmacol Sci. 2012 Jan;33(1):35-41 3096220 - Arch Dermatol. 1986 Nov;122(11):1253-7 21074481 - Cytokine Growth Factor Rev. 2011 Feb;22(1):19-33 18952503 - Clin Immunol. 2009 Mar;130(3):338-46 21752713 - Trends Immunol. 2011 Aug;32(8):380-7 22510809 - Curr Opin Lipidol. 2012 Aug;23(4):377-85 21803849 - Blood. 2011 Sep 22;118(12):e50-61 2921322 - J Clin Invest. 1989 Mar;83(3):796-802 24092747 - Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2715-23 20702809 - Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1773-8 16469089 - J Dermatol. 2006 Jan;33(1):64-7 10634817 - Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):189-97 6771077 - Clin Exp Immunol. 1980 Feb;39(2):455-60 21757618 - Blood. 2011 Oct 6;118(14):3777-84 21438812 - Expert Rev Cardiovasc Ther. 2011 Mar;9(3):329-40 21226578 - N Engl J Med. 2011 Jan 13;364(2):127-35 16215259 - J Lipid Res. 2006 Jan;47(1):51-8 19921193 - Ann Hematol. 2010 Jun;89(6):569-77 10030387 - Atherosclerosis. 1999 Feb;142(2):355-65 16794250 - Blood. 2006 Oct 15;108(8):2520-30 16571879 - N Engl J Med. 2006 Mar 30;354(13):1362-9 21194787 - Eur J Cell Biol. 2011 Jun-Jul;90(6-7):527-35 21757719 - J Biol Chem. 2011 Sep 2;286(35):30926-36 12499438 - J Clin Pathol. 2003 Jan;56(1):64-8 19126043 - Int J Dermatol. 2009 Jan;48(1):1-10 17475889 - J Immunol. 2007 May 15;178(10):6581-9 19843579 - J Leukoc Biol. 2010 Apr;87(4):557-67 22999728 - J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20 21527752 - Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1675-81 19729607 - Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1930-6 |
References_xml | – volume: 130 start-page: 338 year: 2009 end-page: 46 article-title: Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients publication-title: Clin Immunol – volume: 87 start-page: 557 year: 2010 end-page: 67 article-title: Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage publication-title: J Leukoc Biol – volume: 39 start-page: 455 year: 1980 end-page: 60 article-title: Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa publication-title: Clin Exp Immunol – volume: 142 start-page: 355 year: 1999 end-page: 65 article-title: Activation of monocytes causes intracellular accumulation of lipoprotein‐derived lipids and marked hypocholesterolemia–a possible pathogenesis of necrobiotic xanthogranuloma publication-title: Atherosclerosis – volume: 178 start-page: 6581 year: 2007 end-page: 9 article-title: The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV‐1 publication-title: J Immunol – volume: 33 start-page: 35 year: 2012 end-page: 41 article-title: Interleukin‐15 biology and its therapeutic implications in cancer publication-title: Trends Pharmacol Sci – volume: 90 start-page: 527 year: 2011 end-page: 35 article-title: The, “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: novel drug targets with therapeutic potential? publication-title: Eur J Cell Biol – volume: 122 start-page: 1253 year: 1986 end-page: 7 article-title: Normocholesterolemic xanthomatosis publication-title: Arch Dermatol – volume: 83 start-page: 796 year: 1989 end-page: 802 article-title: Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia publication-title: J Clin Invest – volume: 29 start-page: 1930 year: 2009 end-page: 6 article-title: Stimulation of cholesterol efflux by LXR agonists in cholesterol‐loaded human macrophages is ABCA1‐dependent but ABCG1‐independent publication-title: Arterioscler Thromb Vasc Biol – volume: 170 start-page: 478 year: 2010 end-page: 84 article-title: The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis publication-title: Arch Intern Med – volume: 32 start-page: 84 year: 2011 end-page: 92 article-title: CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease publication-title: Eur Heart J – volume: 108 start-page: 2520 year: 2006 end-page: 30 article-title: Dangerous small B‐cell clones publication-title: Blood – volume: 95 start-page: 764 year: 2004 end-page: 72 article-title: Antiinflammatory properties of HDL publication-title: Circ Res – volume: 23 start-page: 377 year: 2012 end-page: 85 article-title: Reverse cholesterol transport in familial hypercholesterolemia publication-title: Curr Opin Lipidol – volume: 56 start-page: 64 year: 2003 end-page: 8 article-title: Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis publication-title: J Clin Pathol – volume: 9 start-page: 329 year: 2011 end-page: 40 article-title: Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization publication-title: Expert Rev Cardiovasc Ther – volume: 22 start-page: 19 year: 2011 end-page: 33 article-title: Role of IL‐15 in immune‐mediated and infectious diseases publication-title: Cytokine Growth Factor Rev – volume: 60 start-page: 1512 year: 2012 end-page: 20 article-title: CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography publication-title: J Am Coll Cardiol – volume: 364 start-page: 127 year: 2011 end-page: 35 article-title: Cholesterol efflux capacity, high‐density lipoprotein function, and atherosclerosis publication-title: N Engl J Med – volume: 354 start-page: 1362 year: 2006 end-page: 9 article-title: Prevalence of monoclonal gammopathy of undetermined significance publication-title: N Engl J Med – volume: 30 start-page: 1773 year: 2010 end-page: 8 article-title: High‐density lipoproteins suppress chemokines and chemokine receptors and publication-title: Arterioscler Thromb Vasc Biol – volume: 33 start-page: 2715 year: 2013 end-page: 23 article-title: Small, dense high‐density lipoprotein‐3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti‐inflammatory, and antiapoptotic functionalities publication-title: Arterioscler Thromb Vasc Biol – volume: 89 start-page: 569 year: 2010 end-page: 77 article-title: Hyperlipidemic myeloma: review of 53 cases publication-title: Ann Hematol – volume: 118 start-page: e50 year: 2011 end-page: 61 article-title: SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset publication-title: Blood – volume: 118 start-page: 3777 year: 2011 end-page: 84 article-title: Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy publication-title: Blood – volume: 286 start-page: 30926 year: 2011 end-page: 36 article-title: Interleukin‐6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response publication-title: J Biol Chem – volume: 48 start-page: 1 year: 2009 end-page: 10 article-title: Necrobiotic xanthogranuloma publication-title: Int J Dermatol – volume: 32 start-page: 380 year: 2011 end-page: 7 article-title: ADAM17: a molecular switch to control inflammation and tissue regeneration publication-title: Trends Immunol – volume: 33 start-page: 64 year: 2006 end-page: 7 article-title: A case of diffuse plane normolipemic xanthomatosis associated with pancytopenia and monoclonal gammopathy publication-title: J Dermatol – volume: 20 start-page: 189 year: 2000 end-page: 97 article-title: Action of atorvastatin in combined hyperlipidemia: preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles publication-title: Arterioscler Thromb Vasc Biol – volume: 118 start-page: e16 year: 2011 end-page: 31 article-title: Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets publication-title: Blood – volume: 31 start-page: 1675 year: 2011 end-page: 81 article-title: Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia publication-title: Arterioscler Thromb Vasc Biol – volume: 47 start-page: 51 year: 2006 end-page: 8 article-title: Reevaluation of the role of the multidrug‐resistant P‐glycoprotein in cellular cholesterol homeostasis publication-title: J Lipid Res – ident: e_1_2_9_2_1 doi: 10.1056/NEJMoa054494 – ident: e_1_2_9_27_1 doi: 10.1016/j.cytogfr.2010.09.003 – ident: e_1_2_9_22_1 doi: 10.1016/j.ejcb.2010.11.005 – ident: e_1_2_9_24_1 doi: 10.1161/ATVBAHA.110.211342 – ident: e_1_2_9_13_1 doi: 10.1001/archinternmed.2009.551 – ident: e_1_2_9_4_1 doi: 10.1001/archderm.1986.01660230045008 – ident: e_1_2_9_17_1 doi: 10.1074/jbc.M111.264325 – ident: e_1_2_9_19_1 doi: 10.1097/MOL.0b013e328353ef07 – ident: e_1_2_9_6_1 doi: 10.1111/j.1365-4632.2009.03912.x – ident: e_1_2_9_28_1 doi: 10.1016/j.tips.2011.09.004 – ident: e_1_2_9_3_1 doi: 10.1182/blood-2006-03-001164 – ident: e_1_2_9_8_1 doi: 10.1007/s00277-009-0849-9 – ident: e_1_2_9_14_1 doi: 10.1161/ATVBAHA.111.227181 – ident: e_1_2_9_15_1 doi: 10.1161/01.ATV.20.1.189 – ident: e_1_2_9_11_1 doi: 10.1136/jcp.56.1.64 – ident: e_1_2_9_31_1 doi: 10.1016/j.clim.2008.09.011 – ident: e_1_2_9_16_1 doi: 10.1194/jlr.M500255-JLR200 – ident: e_1_2_9_23_1 doi: 10.1161/01.RES.0000146094.59640.13 – ident: e_1_2_9_32_1 doi: 10.1189/jlb.0209082 – ident: e_1_2_9_26_1 doi: 10.1016/j.it.2011.05.005 – ident: e_1_2_9_34_1 doi: 10.1182/blood-2011-01-326827 – ident: e_1_2_9_33_1 doi: 10.4049/jimmunol.178.10.6581 – ident: e_1_2_9_5_1 doi: 10.1182/blood-2011-05-356907 – ident: e_1_2_9_9_1 doi: 10.1111/j.1346-8138.2006.00013.x – ident: e_1_2_9_29_1 doi: 10.1016/j.jacc.2012.07.019 – ident: e_1_2_9_30_1 doi: 10.1093/eurheartj/ehq371 – ident: e_1_2_9_21_1 doi: 10.1586/erc.11.16 – volume: 39 start-page: 455 year: 1980 ident: e_1_2_9_10_1 article-title: Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa publication-title: Clin Exp Immunol – ident: e_1_2_9_12_1 doi: 10.1016/S0021-9150(98)00260-3 – ident: e_1_2_9_35_1 doi: 10.1182/blood-2010-12-326355 – ident: e_1_2_9_20_1 doi: 10.1056/NEJMoa1001689 – ident: e_1_2_9_7_1 doi: 10.1172/JCI113960 – ident: e_1_2_9_18_1 doi: 10.1161/ATVBAHA.109.194548 – ident: e_1_2_9_25_1 doi: 10.1161/ATVBAHA.113.301468 – reference: 2921322 - J Clin Invest. 1989 Mar;83(3):796-802 – reference: 21438812 - Expert Rev Cardiovasc Ther. 2011 Mar;9(3):329-40 – reference: 15486323 - Circ Res. 2004 Oct 15;95(8):764-72 – reference: 16215259 - J Lipid Res. 2006 Jan;47(1):51-8 – reference: 22999728 - J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20 – reference: 10030387 - Atherosclerosis. 1999 Feb;142(2):355-65 – reference: 22032984 - Trends Pharmacol Sci. 2012 Jan;33(1):35-41 – reference: 10634817 - Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):189-97 – reference: 21074481 - Cytokine Growth Factor Rev. 2011 Feb;22(1):19-33 – reference: 6771077 - Clin Exp Immunol. 1980 Feb;39(2):455-60 – reference: 12499438 - J Clin Pathol. 2003 Jan;56(1):64-8 – reference: 21653326 - Blood. 2011 Aug 4;118(5):e16-31 – reference: 16794250 - Blood. 2006 Oct 15;108(8):2520-30 – reference: 20212186 - Arch Intern Med. 2010 Mar 8;170(5):478-84 – reference: 16571879 - N Engl J Med. 2006 Mar 30;354(13):1362-9 – reference: 20943670 - Eur Heart J. 2011 Jan;32(1):84-92 – reference: 16469089 - J Dermatol. 2006 Jan;33(1):64-7 – reference: 21757618 - Blood. 2011 Oct 6;118(14):3777-84 – reference: 22510809 - Curr Opin Lipidol. 2012 Aug;23(4):377-85 – reference: 21527752 - Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1675-81 – reference: 21194787 - Eur J Cell Biol. 2011 Jun-Jul;90(6-7):527-35 – reference: 21752713 - Trends Immunol. 2011 Aug;32(8):380-7 – reference: 17475889 - J Immunol. 2007 May 15;178(10):6581-9 – reference: 3096220 - Arch Dermatol. 1986 Nov;122(11):1253-7 – reference: 20702809 - Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1773-8 – reference: 21803849 - Blood. 2011 Sep 22;118(12):e50-61 – reference: 18952503 - Clin Immunol. 2009 Mar;130(3):338-46 – reference: 21757719 - J Biol Chem. 2011 Sep 2;286(35):30926-36 – reference: 19843579 - J Leukoc Biol. 2010 Apr;87(4):557-67 – reference: 21226578 - N Engl J Med. 2011 Jan 13;364(2):127-35 – reference: 19921193 - Ann Hematol. 2010 Jun;89(6):569-77 – reference: 19729607 - Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1930-6 – reference: 19126043 - Int J Dermatol. 2009 Jan;48(1):1-10 – reference: 24092747 - Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2715-23 |
SSID | ssj0013060 |
Score | 2.2770548 |
Snippet | Rationale
Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic... Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma... |
SourceID | pubmedcentral hal proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 269 |
SubjectTerms | Aged Aged, 80 and over Case-Control Studies Cholesterol, HDL - metabolism Cytokines - metabolism Enzyme-Linked Immunosorbent Assay Female HDL histiocytes Humans immune complex Immunoglobulin G - metabolism Inflammation - metabolism Leukocytes, Mononuclear - metabolism Life Sciences Lipid Metabolism - physiology Macrophages - metabolism Male Middle Aged monoclonal immunoglobulin monocyte necrobiotic xanthogranuloma Necrobiotic Xanthogranuloma - etiology Necrobiotic Xanthogranuloma - metabolism Original Paraproteinemias - etiology Paraproteinemias - metabolism Phenotype |
Title | Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.12195 https://www.ncbi.nlm.nih.gov/pubmed/24428816 https://www.proquest.com/docview/1553104997 https://hal.science/hal-03624912 https://pubmed.ncbi.nlm.nih.gov/PMC4279948 |
Volume | 276 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1365-2796 dateEnd: 20231001 omitProxy: true ssIdentifier: ssj0013060 issn: 0954-6820 databaseCode: DIK dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0954-6820 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1365-2796 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0013060 providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4Bh6oX-gTSBwrQS5GCYq8dx1IvqCpaEJSqKhKXKrIdZ0EsSVV2q7a_vjNONmVLhQS3POy8_E3ms2f8GeBNjqBgpmQJsmWfCJ-SSfk8kdpLW1XCVi5kW3zMhifi4FSeLsC72VyYVh-iH3Ajywj_azJwY6-uG3lzfknaCJpmmLOBDDHaz_xvCCENU4SRQogkQz_XaZOGNJ6-6pw3WjyjXMibRPNmvuR1Hhsc0d4j-Dp7hTb_5GJnOrE77vc_6o73fcfHsNwx1Hi3hdQTWPD1U3hw1MXgn8F-SBptaCnjMCQfN1Vc-1bPCavEPw3pEYzQB07HzaWJaaQ3RrA3bkysPx4ZhD7V_vUcTvY-fHk_TLoFGRInuZCJya3MBkopV5ZZLmzqmEu9E2lufc78QBolNYVyS26MTnGfqbRy1mQ6LwWa-gos1U3t1yDWTlfeZsqagRau4pYCjhVCxXPh0XIjeDtrmMJ1auW0aMa46Hst-G2K8G0i2OrLfms1Ov5bahPbty9AstrD3cOCjpEXF5rxHyyCjVnzF2hnFDwxtW-mVwWtr8Sof6giWG3h0F8LKRJHyGcRqDmgzN1s_kx9fha0vAVXWos8gu2Ag1uevzg43j8KWy_uUvglPESOJ9q0uFewNPk-9a-RR03sOixy8Wk9WM0f3Fgb2A |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB7xkKAX1PIMfYXCBaRIideO4yOqinbpLu0BJG6R7TgL0pJUwCL498w4IWUFQuKWh51E88h89ow_A-xlaBSJLpII0bKLuIvJpVwWCeWEKUtuSuurLU7S_hk_PhfnbW0OrYVp-CG6CTfyDP-_JgenCennXl5fXhE5ghLzsMhTFpNRM_73fxIh9ouEEUTwKMVI17KT-kKeru9MPJq_oGrIl1DzZcXkcyTrQ9HRR1hpMWR42Cj9E8y5ahWWRm2WfA0Gvqyzps2G_aR5WJdh5RrGJewS3mtiDBhjlJpO6isd0lxsiOZY2wnh8nCs0Tip98M6nB39Ov3Zj9otEyIrGBeRzoxIe1JKWxRpxk1sExs7y-PMuCxxPaGlUJRsLZjWKsbzRMalNTpVWcHRGTdgoaortwWhsqp0JpVG9xS3JTOUEixRmY5xh74VwP6T4HLb8onTthaTvBtXoJBzL-QAdru2_xoWjVdb_UD5dw2I-Lp_OMzpGsVZrhJ2lwSw86SeHD2B0hu6cvX0JqcdkBIawckANht1dc9CEMPQKNMA5IwiZ142e6e6vPBs25xJpXgWwIFX-Rvfnx__GYz80fZ7Gn-H5f7paJgPBye_P8MHRGS8KWL7Agu311P3FVHPrfnmbfsR4D_95w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xkFAvpfQZoDR9XFopKMnacSz1goDVLgVaVUXiUkW2YwPqkqB2FwG_vjNONmVLVam95WEncfxN5rNn8hngTY6gSFSZRMiWbcRsTCZl84hLy7VzTDvjsy0Os8ER2zvmx3PwfvovTKMP0U24kWX47zUZ-EXpbht5fXZO2giSz8Miy3B4RZToc_orhhD7f4SRQ7AoQ0fXipP6PJ6u7ow7mj-lZMi7TPNuwuRtIus9UX8Zvk7b0CSgfNucjPWmuflN3vF_G_kA7rcUNdxqMLUCc7Z6CEsHbRD-EQx91mhNaxn7OfmwdmFlG0EnrBJeKRIkOEEnOBnV5yqkqd4Q0V6bEdH-8EQh9qn29WM46u9-2R5E7YoMkeEp45HKNc96QghTllnOdGwSE1vD4lzbPLE9rgSXFMstU6VkjPuJiJ3RKpN5ydDWn8BCVVf2GYTSSGd1JrTqSWZcqini6BArNmUWTTeAt9OOKUwrV06rZoyKbtiC76bw7yaA113Zi0ak44-lXmH_dgVIV3uwtV_QMXLjTCbpZRLAy2n3F2hoFD1Rla0nPwpaYCmhAaII4GkDh-5ayJFSxHwWgJgByszNZs9UZ6dezJulQkqWB_DO4-Avz1_sfRwe-K3Vfyn8ApY-7fSL_eHhhzW4h3yPNSly67Aw_j6xz5FTjfWGN52fYOcdzA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Physiopathology+of+necrobiotic+xanthogranuloma+with+monoclonal+gammopathy&rft.jtitle=Journal+of+internal+medicine&rft.au=Szalat%2C+R.&rft.au=Pirault%2C+J.&rft.au=Fermand%2C+J.%E2%80%90P.&rft.au=Carri%C3%A9%2C+A.&rft.date=2014-09-01&rft.issn=0954-6820&rft.eissn=1365-2796&rft.volume=276&rft.issue=3&rft.spage=269&rft.epage=284&rft_id=info:doi/10.1111%2Fjoim.12195&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_joim_12195 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6820&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6820&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6820&client=summon |